In the assessment of 12-month price targets, analysts unveil insights for Myriad Genetics, presenting an average target of ...

Mary Annette PemberICTThe sight of a room full of human cadavers can be off-putting for some, but not for Haley Omeasoo.In ...

The "Genetic Screening Testing for Reproductive Health Market - A Global and Regional Analysis: Focus on Test Type, Application, Technology, End User, and Country-Level Analysis - Analysis and ...

BofA lowered the firm’s price target on Myriad Genetics (MYGN) to $9 from $11 and keeps an Underperform rating on the shares. Sentiment for ...

Show us even just a couple of the best light jackets for men and it’ll trigger a primal, physiological response worthy of ...

While federal employment law applies in both states, the Golden State maintains complex employment laws and regulations, ...

Guggenheim downgraded Myriad Genetics (MYGN) to Neutral from Buy without a price target Based on key opinion leader checks on GeneSight and ...

In the preceding three months, 10 analysts have released ratings for Myriad Genetics MYGN, presenting a wide array of perspectives from bullish to bearish. Summarizing their recent assessments ...

But the company could not build a sustainable business and many of the 15 million people who gave their genetic information to the platform are worried about where their personal data could end up.

It turns out the unique color is caused by a recessive genetic mutation, rather than the expression of a gene known to turn cats white. The pretty black, white, and grey shade—named for a ...

Myriad Genetics, Inc.’s MYGN Oncology growth strategy, which focuses on expanding companion diagnostics and market growth through new clinical guidelines, is poised to drive growth in the ...